News

Dr. Julia Schaft from BioRN is supported as the new spokesperson of the BioRegions working group by Dr. Jürgen Walkenhorst LifeScience Nord and Dr. Jens Hellwage (InfectoGnostics/Thuringia).

From March 16-17, InfectoGnostics partners presented current research results and product innovations in the field of infection diagnostics at the 7th AMR Conference in Basel

Some impressions from the EU ITN TIPAT Winter School in Jena last week. We had the pleasure to organize an Entrepreneurship Day with our startup partners BLINK DX, SmartDyeLivery and Nanozoo in the beautiful new building of BLINK AG.

In two scientific publications, InfectoGnostics researchers with participation of Leibniz IPHT recently presented new bioinformatics tools whose open source code can now be used and further developed free of charge. The software What the Phage enables the detection of phages, while ConsensusPrime…

In the InfectoGnostics accompanying research project "POCT-ambulant", the first two scientific publications have recently appeared in peer-reviewed journals.

Scientists at the InfectoGnostics Research Campus Jena have developed a new microarray that can detect antibodies against a wide range of infectious agents. With a single drop of the patient's blood, it is thus possible to test whether the immune system has responded to a vaccination or if there is…

InfectoGnostics researchers have developed a test that can detect genetic characteristics of the bacterium Staphylococcus aureus and distinguish between more than 700 strains of this pathogen. Virulence factors and resistance genes, including those of the "multiresistant" variants (MRSA), can be…

Together with its partners, the InfectoGnostics Research Campus participated in the AMR Conference in Basel from April 7 to 8, 2022 and presented scientific results and cooperation concepts from Jena. The AMR Conference is considered one of the most important international conferences that…

InfectoGnostics researchers at Jena University Hospital (JUH) and the Leibniz Institute for Photonic Technology (Leibniz-IPHT) have been able to show how irrelevant human DNA can be sorted out already during sequencing with nanopore systems to enable more precise analyses of microbiomes and bring…

InfectoGnostics scientists at the Leibniz Institute of Photonic Technologies (Leibniz-IPHT), together with partners from the United Arab Emirates (UAE), have successfully validated a lateral flow test that was previously developed together with InfectoGnostics' corporate partners Senova and fzmb. In…